Results 281 to 290 of about 266,976 (313)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 2010
Mammalian target of rapamycin (mTOR) protein complex functions as an integration center for various intracellular signaling pathways involving proliferation, cell survival, and angiogenesis. These pathways are frequently abnormally regulated in cancer.
openaire +1 more source
Mammalian target of rapamycin (mTOR) protein complex functions as an integration center for various intracellular signaling pathways involving proliferation, cell survival, and angiogenesis. These pathways are frequently abnormally regulated in cancer.
openaire +1 more source
Gan to kagaku ryoho. Cancer & chemotherapy, 2011
Mammalian target of rapamycin(mTOR)exists downstream in the PI3K/AKT signal transmission pathway that is constantly activated in many cancers. It regulates translation of mRNA that codes for proteins involved in survival signals, such as for the cell cycle and apoptosis, by phosphorylation of p70S6K and 4E-BP1 that are further downstream.
openaire +1 more source
Mammalian target of rapamycin(mTOR)exists downstream in the PI3K/AKT signal transmission pathway that is constantly activated in many cancers. It regulates translation of mRNA that codes for proteins involved in survival signals, such as for the cell cycle and apoptosis, by phosphorylation of p70S6K and 4E-BP1 that are further downstream.
openaire +1 more source
Recent Progress in the Management of Advanced Renal Cell Carcinoma
Ca-A Cancer Journal for Clinicians, 2007Brian I Rini
exaly
mTOR: from growth signal integration to cancer, diabetes and ageing
Nature Reviews Molecular Cell Biology, 2010Roberto Zoncu +2 more
exaly
Rapamycin passes the torch: a new generation of mTOR inhibitors
Nature Reviews Drug Discovery, 2011Michael N Hall
exaly
Current development of mTOR inhibitors as anticancer agents
Nature Reviews Drug Discovery, 2006Guido Kroemer
exaly
mTOR signalling and cellular metabolism are mutual determinants in cancer
Nature Reviews Cancer, 2018Michael N Hall
exaly

